Comparative Effectiveness on Survival of Zoledronic Acid versus Pamidronate in Multiple Myeloma

Zoledronic acid and pamidronate are the two bisphosphonates approved to reduce multiple myeloma skeletal complications in the United States. Little prior evidence exists comparing survival outcomes between the two. We evaluated the incidence of skeletal related events and overall survival in myeloma...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Leuk Lymphoma
Hlavní autoři: Sanfilippo, KM, Gage, B, Luo, S, Weilbaecher, K, Tomasson, M, Vij, R, Colditz, G, Carson, K
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4399231/
https://ncbi.nlm.nih.gov/pubmed/24844358
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2014.924117
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky